stars 1 stars 2 stars 3

Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosis™ for kidney health. We’ve engineered a proprietary solution that successfully enables early-stage, progression risk assessment when it counts the most. Renalytix. Right here, until kidney disease isn’t.™

Renalytix Questions

The Renalytix annual revenue was $520000 in 2026.

James McCullough is the Founder and Chief Executive Officer of Renalytix.

28 people are employed at Renalytix.

Renalytix is based in New York, New York.

The NAICS codes for Renalytix are [62, 621492, 5112, 62149, 6214, 511, 51, 541, 621, 54].

The SIC codes for Renalytix are [87, 873, 73, 80].

Top Renalytix Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users